UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended September 30, 2024.

pdf

Unichem Laboratories Ltd.

23 Oct 2024

486.65

-0.86%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Reply Letter On A Significant Increase In The Volume.

BSE India

Reply letter on a significant increase in the Volume.

pdf

Unichem Laboratories Ltd.

11 Oct 2024

486.65

-0.86%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024.

pdf

Unichem Laboratories Ltd.

04 Oct 2024

486.65

-0.86%

Corp. Note

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Compliance Reg. 39 (3) - Intimation of Loss of Share certificate

pdf

Unichem Laboratories Ltd.

30 Sep 2024

486.65

-0.86%

Board Meeting

UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Purchase of Product approvals and all goodwill associated with Nine (9) ANDAs owned by Bayshore Pharmaceuticals LLC, USA for USD 2,650,000 by the Company and Purchase of USA generics formulations business as a going concern through slump sale ./ transfer of business by Unichem Pharmaceuticals (USA) Inc through assets purchase agreements for USD 10,000,000.

pdf

Is Unichem Laboratories Ltd. worth buying?

102 Votes:

Buy 79.41%

Sell 8.82%

Hold 11.76%